|Videos|December 14, 2019

The Impact of Discovering U=U

Jason Tokumoto, MD, discusses recent developments in HIV treatment and prevention, focusing on the impact of “U=U.”

Segment Description: Jason Tokumoto, MD, infectious disease clinician at the University of California San Francisco Medical Center, discusses the impact of the discovery that U=U.

Interview Transcript (modified slightly for readability):

Contagion®: What do you consider the most significant recent developments in HIV treatment and prevention?

Tokumoto: I think this whole issue of what we call u equals u, which means undetectable equals untransmittable.

Which means that if an HIV positive person takes his or her medications, and the viral load is undetectable — and we defined undetectable as less than 200 copies per ml of the virus — that you will not transmit the virus to the HIV negative person.

That information is taken from sexual encounters. We don't know if that applies to exposure from blood. So an IV drug user, does that apply there? Not clear at this point. But definitely from a sexual standpoint. If your viral load is undetectable on medications, you're not going to give it to the negative person. And I think that's really huge. And what's interesting about that data is that the CDC [Centers for Disease Control and Prevention] was the last organization to accept that, the whole world had accepted that that was true based on good studies. But of course, the United States being more cautious, waited for a while to accept that data.

I think that's a huge difference because sex is something that you want to try to practice as naturally as possible. And I think this gives a little bit more freedom in terms of sexual practice, although you still should use condoms because condoms protect against other STDs. So you really should still be using condoms.


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.